OraSure to Present at the J.P Morgan Healthcare Conference
07 janv. 2025 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that...
CORRECTION - OraQuick® HIV Self-Test Now Approved for Use in Adolescents
07 janv. 2025 08h50 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Tuesday, January 7th by OraSure Technologies, Inc. (NASDAQ: OSUR), please note that the first...
OraQuick® HIV Self-Test Now Approved for Use in Adolescents
07 janv. 2025 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- OraQuick® HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals...
OraSure Technologies Acquires Sherlock Biosciences
19 déc. 2024 16h02 HE
|
OraSure Technologies, Inc.
OraSure Technologies Acquires Sherlock Biosciences
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
02 déc. 2024 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions, today announced that...
OraSure to Participate in Upcoming Investor Conference
18 nov. 2024 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that the company is scheduled to participate in the following investor conference: ...
OraSure Reports Q3 ’24 Revenue of $39.9 Million
06 nov. 2024 16h05 HE
|
OraSure Technologies, Inc.
Q3 GAAP EPS of $(0.06); Q3 Non-GAAP EPS of $(0.01) OraQuick® HCV Self-test receives initial orders following receipt of WHO pre-qualification status Expanding Sample Management applications into...
OraSure to Announce Third Quarter 2024 Financial Results and Host Earnings Call on November 6th
22 oct. 2024 16h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Oct. 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2024 financial results and...
OraSure Technologies Elects Jack Kenny to the Board of Directors
09 sept. 2024 07h05 HE
|
OraSure Technologies, Inc.
BETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced the...
OraSure Reports Q2 ’24 Revenue of $54.3 Million
06 août 2024 16h05 HE
|
OraSure Technologies, Inc.
Q2 GAAP EPS of $(0.01); Q2 Non-GAAP EPS of $0.07 OraQuick® HCV Self-test is the first globally to earn WHO pre-qualification Strong momentum with Syphilis Health Check™ launch Expanding Sample...